Divalent metal-ion transporter 1 is decreased in intestinal epithelial cells and contributes to the anemia in inflammatory bowel disease

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wu, Wei ^a   Song, Yang ^a   He, Chong ^a   Liu, Changqin ^a   Wu, Ruijin ^a   Fang, Leilei ^a   Cong, Yingzi ^b   Miao, Yinglei ^c   Liu, Zhanju ^a  

^a TONGJI UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATION TRANSPORT PROTEIN; HEMOGLOBIN; IRON; METAL TRANSPORTING PROTEIN 1; MONOCLONAL ANTIBODY; PROTEIN KINASE INHIBITOR; SOLUTE CARRIER FAMILY 11- (PROTON-COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 2; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; AGED; ANEMIA; BLOOD; COMPLICATION; CROHN DISEASE; DOWN REGULATION; DRUG EFFECTS; FEMALE; GENETICS; HCT 116 CELL LINE; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANTIBODIES, MONOCLONAL; CATION TRANSPORT PROTEINS; CROHN DISEASE; DOWN-REGULATION; FEMALE; HCT116 CELLS; HEMOGLOBINS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; IRON; MALE; MIDDLE AGED; PROTEIN KINASE INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84947474645     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16344     Document Type: Article

References (38)

1. Sartor, R. B. Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. Gastroenterology 139, 1816-1819 (2010).
2. Liu, Z., Cao, A. T. , Cong, Y. Microbiota regulation of inflammatory bowel disease and colorectal cancer. Semin. Cancer. Biol. 23, 543-552 (2013).
3. Xiao, C. et al. Exome sequencing identifies novel compound heterozygous IFNA4 and IFNA10 mutations as a cause of impaired function in Crohn's disease patients. Sci. Rep. 5, 10514 (2015).
4. Sun, M., He, C., Cong, Y. , Liu, Z. Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. Mucosal Immunol. 8, 969-978 (2015).
5. Gasche, C., Lomer, M. C., Cavill, I. , Weiss, G. Iron, anaemia, and inflammatory bowel diseases. Gut 53, 1190-1197 (2004).
6. Bergamaschi, G. et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica. 95, 199-205 (2010).
7. Horina, J. H. et al. Treatment of anemia in inflammatory bowel disease with recombinant human erythropoietin: results in three patients. Gastroenterology 104, 1828-1831 (1993).
8. Semrin, G. et al. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm. Bowel. Dis. 12, 1101-1106 (2006).
9. Gerasimidis, K. et al. The epidemiology of anemia in pediatric inflammatory bowel disease: prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutrition. Inflamm. Bowel. Dis. 19, 2411-2422 (2013).
10. Van Assche, G. Intravenous iron for the treatment of iron deficiency in IBD: the pendulum is swinging. Am. J. Gastroenterol. 108, 1889-1890 (2013).
11. Reinisch, W., Staun, M., Bhandari, S. , Munoz, M. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J. Crohns Colitis 7, 429-440 (2013).
12. Fuqua, B. K., Vulpe, C. D. , Anderson, G. J. Intestinal iron absorption. J. Trace Elem. Med. Biol. 26, 115-119 (2012).
13. Frazer, D. M., Darshan, D. , Anderson, G. J. Intestinal iron absorption during suckling in mammals. Biometals. 24, 567-574 (2011).
14. Anderson, G. J., Frazer, D. M. , McLaren, G. D. Iron absorption and metabolism. Curr. Opin. Gastroenterol. 25, 129-135 (2009).
15. Anderson, G. J. , Vulpe, C. D. Mammalian iron transport. Cell Mol. Life Sci. 66, 3241-3261 (2009).
16. Theil, E. C. Iron homeostasis and nutritional iron deficiency. J. Nutr. 141, 724S-728S (2011).
17. Urrutia, P. et al. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J. Neurochem. 126, 541-549 (2013).
18. Srivastava, M. D. , Kulaylat, M. N. Gene expression profiles of late colonic Crohn's disease. J. Med. 35, 233-255 (2004).
19. Neurath, M. F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 14, 329-342 (2014).
20. Johnson, D. et al. Tumour necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cells. FEBS Lett. 573, 195-201 (2004).
21. Laftah, A. H. et al. Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice. Biochem. J. 397, 61-67 (2006).
22. Yu, L. et al. Infliximab preferentially induces clinical remission and mucosal healing in short course Crohn's Disease with luminal lesions through balancing abnormal immune response in gut mucosa. Mediators Inflamm. 2015, 793764 (2015).
23. Liu, C. et al. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease. Clin. Exp. Immunol. 173, 102-111 (2013).
24. Munoz, M., Garcia-Erce, J. A. , Remacha, A. F. Disorders of iron metabolism. Part II: iron deficiency and iron overload. J. Clin. Pathol. 64, 287-296 (2011).
25. Canonne-Hergaux, F. , Gros, P. Expression of the iron transporter DMT1 in kidney from normal and anemic mk mice. Kidney Int. 62, 147-156 (2002).
26. Filmann, N. et al. Prevalence of anemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta-analysis. Inflamm. Bowel. Dis. 20, 936-945 (2014).
27. Ott, C. , Scholmerich, J. Extraintestinal manifestations and complications in IBD. Nat. Rev. Gastroenterol. Hepatol. 10, 585-595 (2013).
28. Headstrom, P. D., Rulyak, S. J. , Lee, S. D. Prevalence of and risk factors for vitamin B12 deficiency in patients with Crohn's disease. Inflamm. Bowel. Dis. 14, 217-223 (2008).
29. Yakut, M., Ustun, Y., Kabacam, G. , Soykan, I. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur. J. Intern. Med. 21, 320-323 (2010).
30. Oustamanolakis, P., Koutroubakis, I. E. , Kouroumalis, E. A. Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J. Crohns Colitis 5, 381-391 (2011).
31. Weiss, G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev. 16, 87-96 (2002).
32. Darshan, D., Wilkins, S. J., Frazer, D. M. , Anderson, G. J. Reduced expression of ferroportin-1 mediates hyporesponsiveness of suckling rats to stimuli that reduce iron absorption. Gastroenterology 141, 300-309 (2011).
33. Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093 (2004).
34. Perrier, C. et al. Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitis. Inflamm. Bowel. Dis. 19, 246-253 (2013).
35. Su, J. et al. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease. Inflamm. Bowel. Dis. 19, 720-728 (2013).
36. Ge R. et al. Insulin-like growth factor-1 endues monocytes with immune suppressive ability to inhibit inflammation in the intestine. Sci. Rep. 5, 7735 (2015).
37. Liu, Z. et al. Chemokine CXCL11 links microbial stimuli to intestinal inflammation. Clin. Exp. Immunol. 164, 396-406 (2011).
38. Liu, Z. et al. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J. Leukoc. Biol. 89, 597-606 (2011).